| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/16/2013 | US20130123359 Five and fifteen carbon fatty acids for treating metabolic disorders and as nutritional supplements |
| 05/16/2013 | US20130123358 Metabolic Benefits to Butyrate as a Chronic Diet Supplement |
| 05/16/2013 | US20130123357 Methods for Providing Enhanced Resveratrol Activity Using 4-Acetoxy-Resveratrol |
| 05/16/2013 | US20130123355 Fatty acids and metal ions compositions and uses thereof |
| 05/16/2013 | US20130123354 Soluble guanylate cyclase (sgc) modulators for treatment of lipid related disorders |
| 05/16/2013 | US20130123353 Dronedarone solid dispersion and preparation method thereof |
| 05/16/2013 | US20130123352 Xanthanodien for the treatment of cancer |
| 05/16/2013 | US20130123345 Method of treating a viral infection dysfunction by disrupting an adenosine receptor pathway |
| 05/16/2013 | US20130123344 Method of preventing or treating viral infection |
| 05/16/2013 | US20130123343 Methods for Reverting Methylation by Targeting Methyltransferase and Compositions Useful Therefor |
| 05/16/2013 | US20130123339 Compositions and methods for silencing apolipoprotein b |
| 05/16/2013 | US20130123333 Nucleic Acid Functionalized Nanoparticles for Therapeutic Applications |
| 05/16/2013 | US20130123330 Dual Targeted siRNA Therapeutics for Treatment of Diabetic Retinopathy and Other Ocular Neovascularization Diseases |
| 05/16/2013 | US20130123328 Methods and compositions for treating cancer |
| 05/16/2013 | US20130123327 Combined use of prame inhibitors and hdac inhibitors |
| 05/16/2013 | US20130123326 Allosteric binding compounds |
| 05/16/2013 | US20130123325 Use of boceprevir and related compounds in atherosclerosis, heart failure, renal diseases, liver diseases or inflammatory diseases |
| 05/16/2013 | US20130123320 Topical composition for pain relief |
| 05/16/2013 | US20130123319 Medthod of Treating a systemic inflammatory disorder and damaged internal tissues |
| 05/16/2013 | US20130123318 Anti-fungal formulation |
| 05/16/2013 | US20130123317 2-((r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide crystalline form 1 |
| 05/16/2013 | US20130123316 Bendamustine Pharmaceutical Compositions |
| 05/16/2013 | US20130123315 Substituted imidazolones, compositions containing such compounds and methods of use |
| 05/16/2013 | US20130123312 Compositions and Methods of Using R(+) Pramipexole |
| 05/16/2013 | US20130123311 Modulators of pharmacokinetic properties of therapeutics |
| 05/16/2013 | US20130123309 Method for reducing microbial load for individuals with elevated risk conditions |
| 05/16/2013 | US20130123306 Inhibition of Mitogen-activated Protein Kinases in Cardiovascular Disease |
| 05/16/2013 | US20130123303 Pharmaceutical compositions comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions |
| 05/16/2013 | US20130123301 Crystalline salts of quinoline compounds and methods for preparing them |
| 05/16/2013 | US20130123298 Pharmaceutical composition for the prevention of perioperative arterial hypotension in humans |
| 05/16/2013 | US20130123295 Treatment of neuropathic pain with n-methyl-d-aspartate (nmda) receptor antagonists |
| 05/16/2013 | US20130123293 Opioid-containing oral pharmaceutical compositions and methods |
| 05/16/2013 | US20130123291 Benzodioxole or benzodioxepine heterocyclic compounds as phosphodiesterase inhibitors |
| 05/16/2013 | US20130123290 Pyrimidylaminobenzamide Derivatives for Treatment of Neurofibromatosis |
| 05/16/2013 | US20130123286 Novel Fused Heterocyclic Derivatives Useful as c-Met Tyrosine Kinase Inhibitors |
| 05/16/2013 | US20130123285 Compositions and Methods for Targeting A3G:RNA Complexes |
| 05/16/2013 | US20130123280 A2b adenosine receptor antagonists |
| 05/16/2013 | US20130123279 Crystal of thienopyrimidine derivative |
| 05/16/2013 | US20130123276 Use of telaprevir and related compounds in atherosclerosis, heart failure, renal diseases, liver diseases or inflammatory diseases |
| 05/16/2013 | US20130123274 Antitumor Agent Using Compounds Having Kinase Inhibitory Effect in Combination |
| 05/16/2013 | US20130123273 Methods of targeting pten mutant diseases and compositions therefor |
| 05/16/2013 | US20130123272 Organic compound for use in the treatment of liver cancer |
| 05/16/2013 | US20130123270 Substituted piperazinyl-pyrrolidine compounds useful as chemokine receptor antagonists |
| 05/16/2013 | US20130123269 Novel heterocycle compounds and uses thereof |
| 05/16/2013 | US20130123268 3,3-disubstituted-(8-aza-bicyclo[3.2.1]oct-8-yl)-[5-(1h-pyrazol-4-yl)-thiophen-3-yl]-methanones as inhibitors of 11 (beta)-hsd1 |
| 05/16/2013 | US20130123266 Treatment of a pathology linked to an excessive effect of tnf with a benzene sulphonamide compound |
| 05/16/2013 | US20130123265 Compounds that modulate intracellular calcium |
| 05/16/2013 | US20130123264 Compositions and methods for treatment of inflammatory bowel disorders and intestinal cancers |
| 05/16/2013 | US20130123263 Benzopyran and benzoxepin pi3k inhibitor compounds and methods of use |
| 05/16/2013 | US20130123261 Isoxazoline compounds in type 2 diabetes and other maladies |
| 05/16/2013 | US20130123260 Methods |
| 05/16/2013 | US20130123255 Combination of a pi3k inhibitor and a mek inhibitor |
| 05/16/2013 | US20130123254 Pharmaceutically acceptable mglur5 positive allosteric modulators and their methods of identification |
| 05/16/2013 | US20130123252 2,3,5-Trisubstituted Thiophene Compounds and Uses Thereof |
| 05/16/2013 | US20130123251 Benzoxazine derivatives and uses thereof |
| 05/16/2013 | US20130123248 Pharmacological modulation of positive ampa receptor modulator effects on neurotrophin expression |
| 05/16/2013 | US20130123246 Modulators of indoleamine 2,3-dioxygenase and methods of using the same |
| 05/16/2013 | US20130123245 Methods for alleviating chronic pain and improving performance of cattle undergoing dehorning or castration |
| 05/16/2013 | US20130123244 Hetero-Bicyclic Derivatives as HCV Inhibitors |
| 05/16/2013 | US20130123242 Compounds and methods for the treatment or prevention of flavivirus infections |
| 05/16/2013 | US20130123240 Method of using biothionol and biothionol-like compounds as anti-angiogenic agents |
| 05/16/2013 | US20130123238 Use of (+)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane to treat addictive and alcohol-related disorders |
| 05/16/2013 | US20130123237 Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents |
| 05/16/2013 | US20130123230 2-Thiopyrimidinones |
| 05/16/2013 | US20130123229 CB1 Receptor Antagonists and Uses Thereof |
| 05/16/2013 | US20130123228 Promoting axon regeneration in the adult cns through control of protein translation |
| 05/16/2013 | US20130123227 Novel organo-palladium complexes |
| 05/16/2013 | US20130123226 Pharamceutical compositions and methods of use 4-pregenen-11beta-17-21-triol-3,20-dione derivatives |
| 05/16/2013 | US20130123222 Synergistic Anti-Cancer Activity of SR16388 with Anti-Mitotic Drugs |
| 05/16/2013 | US20130123221 Compositions and methods for the treatment of skin diseases |
| 05/16/2013 | US20130123217 Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits |
| 05/16/2013 | US20130123214 Use of delta tocopherol for the treatment of lysosomal storage disorders |
| 05/16/2013 | US20130123212 Anti-fatigue composition, formulation and use thereof |
| 05/16/2013 | US20130123211 Pectic enzyme treated pectin, method of producing the same and application thereof |
| 05/16/2013 | US20130123209 Methods of treating hepatic encephalopathy |
| 05/16/2013 | US20130123208 Method of treating multiple sclerosis with adenosine receptor agonists |
| 05/16/2013 | US20130123207 Compositions Containing Resveratrol and Nucleotides |
| 05/16/2013 | US20130123206 Treatment of metabolic syndrome and insulin resistance with citrus flavanones |
| 05/16/2013 | US20130123204 Method for treating hepatitis b |
| 05/16/2013 | US20130123203 Methods and compositions for treatment of autism |
| 05/16/2013 | US20130123185 Methods of treating and diagnosing acute chest syndrome |
| 05/16/2013 | US20130123172 Treatment of Type 2 Diabetes With FTY720 |
| 05/16/2013 | US20130123133 Screening methods |
| 05/16/2013 | US20130122171 Dietary Fiber Composition |
| 05/16/2013 | US20130122122 Method for preparing novel processed ginseng or an extract thereof, the usually minute ginsenoside content of which is increased |
| 05/16/2013 | US20130122114 Methods and compositions for inhibiting the nuclear factor kappab pathway |
| 05/16/2013 | US20130122113 Antitumoral combination comprising ombrabulin, a taxane derivative and a platinum derivative |
| 05/16/2013 | US20130122111 Method for treatment of advanced solid tumors |
| 05/16/2013 | US20130122110 Anti-human urothelial carcinoma of supercritical carbon dioxide extract of cinnamomum subavenium, and the preparation process and uses |
| 05/16/2013 | US20130122098 Method and composition to improve absorption of therapeutic agents |
| 05/16/2013 | US20130122093 Formulations of a src/abl inhibitor |
| 05/16/2013 | US20130122092 Three-phase controlled-release tablet comprising melatonin and process of preparation |
| 05/16/2013 | US20130122091 Polydeoxyribonucleotide-based compositions and their methods of use |
| 05/16/2013 | US20130122090 Multiple Unit Tablet Composition |
| 05/16/2013 | US20130122089 Dpp iv inhibitor formulations |
| 05/16/2013 | US20130122088 Tablet formulations containing 8-[-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one salts and tablets made therefrom |
| 05/16/2013 | US20130122085 Pharmaceutical compositions of selective androgen receptor modulators and methods of use thereof |
| 05/16/2013 | US20130122083 Dna vaccines encoding heat shock proteins |
| 05/16/2013 | US20130122081 Liposomes useful for drug delivery |
| 05/16/2013 | US20130122079 Transdermal adhesive compositions, devices and methods |